Hints and tips:
Related Special Reports
...DeepMind is also using AI to explore other areas of biology and accelerate research into drug discovery and delivery, material science, mathematics, weather prediction and nuclear fusion technology....
...Nippon Paint’s co-president Yuichiro Wakatsuki said he remains “cautiously optimistic” about China despite investor concerns about the impact of the slowdown for the Japanese group, which makes 35 per cent...
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
...The speedy delivery service — which in some places will use drones to deliver drugs — is expected to expand to other US cities by the end of the year....
...Speaking to the Financial Times, Demis Hassabis, who co-founded Google’s AI unit and also leads the drugs offshoot Isomorphic Labs, said the goal was to reduce the discovery stage — when potential drugs...
...The drug is not yet approved in the US or Europe....
...BYD reported a 42 per cent fall in its electric vehicle deliveries in the first three months of the year compared to the final quarter of 2023, allowing Tesla to reclaim the crown as the world’s largest...
...It is the first drug found to slow the progression of the disease, rather than just treat the symptoms....
...Significant differences between richer and poorer nations are threatening progress on a key pandemic treaty, with officials warning that the planned May deadline for delivery of the global accord may be...
...There have been large investments in vaccine delivery systems in recent years, such as the mRNA technology used for the BioNTech/Pfizer and Moderna Covid-19 vaccines....
...Still, Wedbush Securities analyst Dan Ives said it was an important quarter for Tesla to show strong deliveries and momentum heading into 2024....
...“We believe Soho House & Co is a zero,” the short seller wrote in a report released this week where it disclosed a bet against the business....
...DeepMind, and others, are also using AI to create new materials, discover new drugs, solve mathematical conjectures, forecast the weather more accurately and improve the efficiency of experimental nuclear...
...Some ecommerce platforms have been willing to pay close to double what general cargo customers are charged in some cases, in order to secure sufficient capacity to meet rigorous delivery schedules, according...
...This week’s trading update from world-leader Contemporary Amperex Technology Co. Ltd. proved those wrong. The battery group’s full-year earnings should handily beat analyst expectations....
...In the UK, Eisai submitted the drug for approval in May....
...In Canada, the first big industrial country to legalise marijuana, cannabis companies have struggled to compete with black market dealers, who offer services such as home delivery and often lower prices....
...European defence: MBDA, a pan-European weapons maker that successfully overcame national interests to compete with US rivals, is being held up as a model of defence co-operation needed in the region....
...Selling to consumers online, Ola Electric has suffered customer complaints about delayed deliveries and problems with its aftersales service....
...It has a thin pipeline of drugs under development and an earnings structure that is heavily dependent on royalty income from HIV drugs....
...labour productivity and GDP estimates US: NAHB Housing Market Index and monthly retail sales figures Results: Airbus FY, Applied Materials Q1, Centrica FY, Commerzbank Q4, Consolidated Edison FY, Deere & Co...
...Singh, FTX’s former head of engineering, is the last of three central witnesses co-operating with federal prosecutors in the trial. FTX had promoted itself widely before failing last November....
...“They’ve challenged the competition on price and delivery schedule, and they’ve taken business from us as well,” said an Asia-based executive from a leading US defence firm....
...The US Food and Drug Administration in January approved lecanemab, a drug co-developed by Japanese drugmaker Eisai and US biotech Biogen, under an accelerated process....
International Edition